Contact: Pat Smith, Lyme Disease Association, Inc. email: [email protected] or 888-366-6611 For Immediate Release A FIRST! LYME & TICK-BORNE DISEASES RESEARCH CENTER OPENS AT COLUMBIA THROUGH PARTNERSHIP WITH LYME DISEASE […]
Jim is a microbiologist and has conducted antibiotic discovery research for over 30 years in big pharma and academia. Jim is currently a supervisory microbiologist at the New Jersey Department of Health conducting viral (arboviruses and covid-19) surveillance for the state. He is starting a multi-partner plan to institute a state-wide tick surveillance and testing program for the state of New Jersey.
The Lyme Disease Association (LDA) has been funding research nationwide over its 31 year history, awarding 123 research grants to date Click here for list of grants. To date, 60 […]
The Molecular Therapy Journal (Pine M., et al.) 08.01.2023, published “Development of an mRNA-lipid nanoparticle vaccine against Lyme disease.” In this study, scientists propose using a new method called “mRNA-LNP” to create a Lyme disease vaccine, similar to the successful COVID-19 vaccines. The vaccine would target a specific protein in the bacteria Borrelia burgdorferi that causes Lyme disease, called OspA. This protein is found on the surface of B. burgdorferi and is essential for its survival in ticks. By targeting this bacterium, the vaccine aims to prevent the bacteria from infecting humans when bitten by ticks.
In 1998, there was an alum-adjuvanted recombinant OspA protein vaccine release called LYMErix™, that showed to decrease Lyme disease by 75% within a year, but the vaccine was removed from the market in 2002, just four years after its release. Since then, there has been no FDA-approved vaccine for Lyme disease, while cases continue to rise.
International Journal of General Medicine (Johnson, L; et al.) published 6.17.23 “Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness.” In this study researchers examined the outcome differences between men and women with Lyme disease. Investigators analyzed self-reported clinical data from 2170 patients in the MyLymeData patient registry, as well as review of other Lyme disease studies.
US Biologic, Inc., developer and distributor of oral-delivery vaccines, has announced USDA Conditional Licensure of its novel oral vaccine against the spread of Borrelia burgdorferi in wildlife.
Dr. Daniel Cameron graduated from the University of Minnesota School of Medicine and their Department of Epidemiology. He completed residencies at both Beth Israel Medical Center and Mt. Sinai in New York City. Dr. Cameron has led International Lyme and Associated Disease Society (ILADS) twice as their president. He is widely recognized as author of ILADS practice guidelines, Lyme disease science blogs, and Inside Lyme Podcasts. His latest book is titled, “An Expert’s Guide on Navigating Lyme disease.” He continues to see patients in his private practice in Mt. Kisco, New York.
John Aucott, MD
Associate Professor, Medicine
Medical Director, Lyme Disease Clinical Research Center, Department of Medicine, Johns Hopkins University School of Medicine
Persistent Symptoms of Lyme Disease
The Lyme Disease Association (LDA) awards grants in three different areas of its mission: Research, Education, and Patient Support (LymeAid 4 Kids). The sections below highlights each area of grant support. Click below for the summary […]
The LDA has a long history of funding/supporting research projects that lead to real results. Below is the list of links to peer-reviewed articles that acknowledge LDA’s funding/support. Click on […]
LDA Doctor Referral System © Terms & Conditions and Guidelines
Save this Information for Your Records:
About LDA DOCTOR REFERRAL SYSTEM ©
Welcome to the Lyme Disease Association’s LDA Doctor Referral System ©. LDA made updates and enhancements to its prior system and has launched a new site to provide patients with information about doctors, other practitioners, testing labs, and pharmacies that are knowledgeable about chronic Lyme disease and often about many other tick-borne diseases (TBD). Many of the doctors listed are often referred to as Lyme Literate Physicians/Doctors (LLMD). Tens of thousands of patients have successfully used the prior LDA system to locate Lyme and TBD resources.
Terms & Conditions and Guidelines
Because there is a negative political climate surrounding Lyme disease, many LLMDs do not want their names posted outright on the internet. LDA has tried to balance the doctors’ wishes with patients’ need to find a doctor. This new system is a result of that compromise and therefore:
Because of the limited number of physicians treating chronic Lyme disease nationwide, some states, and in some instances, entire regions, may not have any treating physicians who follow flexible treating approaches such as those in the International Lyme & Associated Diseases Society (ILADS) Guidelines, Evidence Assessments and Guideline Recommendations in Lyme Disease: The Clinical Management of Known Tick Bites, Erythema Migrans Rashes and Persistent Disease. In the event that the LDA Doctor Referral System © contains no Lyme or TBD resource listings in a given area, the closest possible option(s) will populate based on the location entered and specaialty/ies selected. The LDA appreciates any changes in provider information that you may find and make us aware of so we can investigate.